nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
|
McIntosh, Christopher H.S. |
|
2005 |
128 |
2 |
p. 159-165 7 p. |
artikel |
2 |
Editorial Board
|
|
|
2005 |
128 |
2 |
p. IFC- 1 p. |
artikel |
3 |
Festschrift for Werner Creutzfeldt
|
Unger, Roger H. |
|
2005 |
128 |
2 |
p. 85- 1 p. |
artikel |
4 |
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
|
Hansotia, Tanya |
|
2005 |
128 |
2 |
p. 125-134 10 p. |
artikel |
5 |
Glucagon-like peptide 1 and its derivatives in the treatment of diabetes
|
Nauck, Michael A. |
|
2005 |
128 |
2 |
p. 135-148 14 p. |
artikel |
6 |
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
|
Larsen, Philip J. |
|
2005 |
128 |
2 |
p. 97-107 11 p. |
artikel |
7 |
Glycaemic effects of incretins in Type 1 diabetes mellitus
|
Dupre, John |
|
2005 |
128 |
2 |
p. 149-157 9 p. |
artikel |
8 |
The discovery of glucagon-like peptide 1
|
Lund, P. Kay |
|
2005 |
128 |
2 |
p. 93-96 4 p. |
artikel |
9 |
The physiological role of GLP-1 in human: incretin, ileal brake or more?
|
Schirra, Jörg |
|
2005 |
128 |
2 |
p. 109-115 7 p. |
artikel |
10 |
The [pre-] history of the incretin concept
|
Creutzfeldt, Werner |
|
2005 |
128 |
2 |
p. 87-91 5 p. |
artikel |
11 |
What do we know about the secretion and degradation of incretin hormones?
|
Deacon, Carolyn F. |
|
2005 |
128 |
2 |
p. 117-124 8 p. |
artikel |